Medical device manufacturers will have a clearer picture of the post-Brexit system of medical device regulation in the UK once a number of focus groups, to be appointed by the Medicines and Healthcare products regulatory Agency (MHRA), can get down to developing key aspects of guidance that will accompany the new regulations.
The focus groups will base their work on the government’s response to the MHRA’s 2021 UK regulatory consultation. The new...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?